Seven new triterpenoid saponins (1-7), together with three known ones (8-10), were isolated from Ilex pubescens. Elucidation of their structures was performed based on high-resolution electrospray ionisation mass spectrometry (HR-ESI-MS), infrared spectra (IR), and nuclear magnetic resonance (NMR) spectroscopic data. The anti-inflammatory activity of the isolates toward lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages was investigated. The results demonstrated that compounds 3, 5, and 6 inhibited the expression of inducible nitric oxide synthase (iNOS) protein in comparison with LPS stimulation in RAW264.7 cells.
Introduction
Ilex pubescens, belonging to the plant family Aquifoliaceae, is widely distributed throughout the south of China. The roots and leaves of Ilex pubescens have been used in folk medicine for treating thromboangiitis obliterans [1] , coronary heart disease [2] , and peripheral vascular diseases [3] . The primary components that have been reported from this plant include triterpenoids [4] , phenolic glycosides [5] , lignan glycosides [6] , hemiterpene glycosides [7] , and flavonoids [8] . All of the components described above play an important role related to several bioactivities, such as anti-inflammatory [9] [10] [11] [12] , anticoagulant [13] , and antithrombotic activities [14] .
Lipopolysaccharide (LPS)-induced macrophages are widely used to study inflammatory responses in vitro [15] . Macrophages are versatile cells that play many roles, and can be activated by external stimuli, such as LPS, to release excessive amounts of inflammatory mediators, including prostaglandin E 2 (PGE 2 ), cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) [16, 17] . Moreover, iNOS and COX-2 are considered to be the most important inflammatory mediators [16, 18] . In our preliminary research, 27 triterpenoid saponins were isolated from Ilex pubescens, and some of them showed remarkable anti-inflammatory activity [19] . However, whether other compounds from this plant have anti-inflammatory activity is still unclear. Therefore, we used an LPS-induced macrophage inflammatory model to determine the effect of 10 compounds on the expression levels of iNOS and COX-2 protein.
Molecules 2018, 23, 1426; doi:10.3390/molecules23061426
www.mdpi.com/journal/molecules
Results

Characterization of the Compounds
Pubescenoside E (1) (Figure 1 ) was isolated as a white amorphous powder, and the molecular formula was deduced to be C 47 H 74 O 17 based on the quasi-molecular ion peak [M + COOH] − at m/z 955.4910 (calcd. 955.4908) in the negative-ion HR-ESI-MS ( Figure S1 , see Supplementary Materials). The sugar component of acid-hydrolyzed 1 gave xylose, glucose, and rhamnose. The glucose and xylose were determined to be D-configuration and the rhamnose be L-configuration, via thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC) analyses. The IR spectrum demonstrated the presence of hydroxyl (3426 cm −1 ), alkyl (2938 cm −1 ), carbonyl (1703 cm −1 ), and double bond (1644 cm −1 ) groups. The 1 H NMR and 13 C NMR (Tables 1 and 2) [20] , their structures were very similar, except for the additional sugar units at C-3 in 1. The heteronuclear multiple bond correlation (HMBC) analysis results were as follows: from H-3 to C-4, C-23, C-24, and inner-Xyl-C-1; from H-12 to C-9, C-11, C-13, and C-14; from H-18 to C-14, C-16, C-17, and C-22; and from CH 3 The molecular formula of Pubescenoside F (2), a white amorphous powder, was determined to be C 53 H 84 O 22 by the HRESIMS ion at m/z 1071.5388 [M − H] − (calcd. 1071.5381) and NMR data. The IR spectrum revealed the existence of hydroxyl, olefinic, and carboxyl absorption bands. The sugar components of acid-hydrolyzed 2 included D-Xylose, D-glucoses, and L-rhamnose, as identified by TLC and HPLC analyses. The 13 C NMR spectrum (Table 2) showed 53 carbon signals, including 23 carbon signals belonging to the sugar units and 30 carbon signals belonging to the aglycone part. It also revealed one ketone group at δ C 212.3 (C-19), one carboxyl at δ C 175.1 (C-28), and four anomeric carbons. The 1 H NMR spectrum (Table 1) of 2 displayed signals assignable to six angular methyl groups at δ H 0.76, 0.82, 1.03 (6H), 1.32, and 2.13 and one methyl doublet at δ H 1.04. The structure of 2 resembled that of 1, except for an additional glucose unit at C-28. The HMBC from Glc-H-1 to C-28 and inner-Xyl-H-1 to C-3 demonstrated glycosylation sites at the 28-O-and 3-O-positions. Eventually, compound 2 was elucidated as [21] were highly similar, with the main difference being the type and connection of the sugar at C-3. The HMBC analysis results were as follows: from H-12 to C-9 and C-14; from H-24 to C-3, C-4, and C-5; from H-27 to C-13, C-14, and C-15; from H-29 to C-19, C-20, and C-21; from inner-Xyl-H-1 to C-3; and from the intermediate-Glc-H-1 to the inner-Xyl-C-2. When combined with comprehensive analyses of 1 H-1 H COSY, HMBC, HSQC, and NOESY NMR spectra, we identified the structure of compound 3 to be β- 2)]-β-D-glucooyranosyl}oleanolicacid 28-β-D-glucopyranosyl ester [21] were highly similar, with the main difference being the type and connection of the sugar at C-3. The HMBC analysis results were as follows: from H-12 to C-9 and C-14; from H-24 to C-3, C-4, and C-5; from H-27 to C-13, C-14, and C-15; from H-29 to C-19, C-20, and C-21; from inner-Xyl-H-1 to C-3; and from the intermediate-Glc-H-1 to the inner-Xyl-C-2. When combined with comprehensive analyses of 1 H-1 H COSY, HMBC, HSQC, and NOESY NMR spectra, we identified the structure of compound 3 to be (Tables 1 and 2 ) revealed the presence of one tri-substituted double bond (δC 134.6, C-9; δH 6.58, δC 128.6, C-11); another tri-substituted double bond (δH 5.61, δC 125.8, C-12; δC 138.6, C-13); one ester carbonyl carbon at C-28 (δC 176.5); four anomeric signals (δH 4.84, δC 106.1; δH (Table 1 ) of 7 showed six singlets for tertiary methyls at δ H 0.89, 1.14, 1.18, 1.42 (6H), and 1.73, and one methyl doublet at δ H 1.11. Furthermore, signals for one tri-substituted double bond (δ H 5.57, δ C 128.4, C-12; δ C 139.3, C-13), one ester carbonyl carbon at C-28 (δ C 177.3), one xylopyranose linked to C-3 of the aglycone, and one β-D-glucopyranose linked to C-28 of the aglycone were observed. The HMBC analysis results were as follows: from H-12 to C-9, C-14, and C-18; from H-18 to C-16, C-17, C-19, and C-20; from H-23 to C-3, C-4 and C-5; from H-25 to C-1, C-5, C-9 and C-10; from H-30 to C-19, C-20, and C-21; and from inner-Xyl-H-1 to C-3. The difference between compound 7 and ilexpublesnin E [4] was that compound 7 had sulfonylation on the hydroxyl attached to Xyl-C-2, whereas ilexpublesnin E is connected to three sugar units at C-3. Therefore, based on the above analysis, compound 7 was deduced as β-D-glucopyranosyl 3β-[(2-O-sulfo-β-D-xylopyranosyl)oxy]-19α-hydroxy-urs-12-en-28-oate (Figure 1) .
Additionally, three known compounds (8-10) (Figure 1 ) were also isolated, and their structures were identified as ilexpublesnin I (8) [4] , ilexoside O (9) [2] , and ilexpublesnin J (10) [4] , by comparison of their 1 H and 13 C NMR, as well as MS data with reported values. 
Anti-Inflammatory Activity
The anti-inflammatory activity of compounds 1-10 was evaluated by utilizing a LPS-stimulated RAW264.7 cell model. As presented in Figure 4 , when compared with LPS stimulation in RAW264.7 cells, compounds 3, 5, and 6 exhibited inhibitory effects on the expression of iNOS protein, and the positive control drug dexamethasone (DEX) notably inhibited the expression of iNOS and COX-2 protein. The effects of DEX intervention suggested that the experimental procedure was adequate. 
Discussion
In summary, seven new triterpenoid saponins, named Pubescenosides E-K, together with three known ones, were isolated from the roots of Ilex pubescens. Elucidation of their structures was performed based on extensive spectroscopic analyses. The anti-inflammatory activity of the isolates 
In summary, seven new triterpenoid saponins, named Pubescenosides E-K, together with three known ones, were isolated from the roots of Ilex pubescens. Elucidation of their structures was performed based on extensive spectroscopic analyses. The anti-inflammatory activity of the isolates toward lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages was investigated. The results demonstrated that compounds 3, 5, and 6 inhibited iNOS protein expression in LPS-stimulated RAW264.7 cells with dexamethasone as a positive control. The findings revealed that compounds 3, 5, and 6 might have anti-inflammatory activity and might have potential value in anti-inflammatory treatments.
Materials and Methods
General Experimental Procedures
A Jasco P-1020 digital polarimeter (Jasco, Tokyo, Japan) was used to measure the optical rotations at the sodium D line (589 nm). IR spectra were collected with a Jasco Fourier transform (FT)/IR-480 plus spectrophotometer (Jasco, Tokyo, Japan) for scanning the IR spectrum with KBr pellets. HRESIMS data were acquired on an Agilent 6540 Q-TOF mass spectrometer (Agilent Technologies, Palo Alto, CA, United States). The 1D and 2D NMR spectra were obtained using a Bruker AV-400 or a Bruker AV-600 spectrophotometer (Bruker, Faellanden, Switzerland), with tetramethylsilanein pyridine-d 5 as an internal standard. Semi-preparative HPLC was carried out with a LC-6AD pump and SPD-M20A detector on an Inertsil PREP-ODS (10 µm, 20 × 250 mm) column (Gl Sciences Inc., Eindhoven, Netherlands). Silica gel (200-300 mesh, Qingdao Marine Chemical Plant, Qingdao, China), Sephadex LH-20 gel (25-100 µm, GE Healthcare, Biosciences AB, Uppsala, Sweden), and reverse phase C18 (50 µm, YMC, Kyoto, Japan) were used for column chromatography (CC). All reagents used were purchased from Tianjin Damao Chemical Company (Damao, Tianjin, China).
Plant Material
The roots of Ilex pubescens were collected near Conghua City, Guangdong Province, China, in July 2012, and identified by Prof. Guangxiong Zhou of the College of Pharmacy, Jinan University. The voucher specimen (12071002) is stored in the International Institute for Translational Chinese Medicine, Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
